AntibodyLimited DatastaleBristol-Myers SquibbPreclinical
nivolumab (Opdivo, Immuno-oncology-based therapy, excluding nivolumab-based regimens, Immuno-oncology-based therapy (excluding nivolumab-based regimens) with chemotherapy)
Non-small Cell Lung Cancer (NSCLC) · Non-small Cell Lung Cancer (NSCLC)
#Non-smallCellLungCancerNSCLC#Antibody#Preclinical#monoclonal-antibody#Bristol-Myers
Trials 1Status Recruiting